• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

我有一种感觉:微生物组正在影响个性化医学的概念和实验观点。

I've A Feeling: Microbiota Impacting the Conceptual and Experimental Perspectives of Personalized Medicine.

机构信息

Department of Experimental and Clinical Medicine, University of Florence, Largo Brambilla, 03 50134, Firenze, Italy.

Department of Biomedicine, Azienda Ospedaliera Universitaria Careggi (AOUC), Largo Brambilla, 03 50134, Firenze, Italy.

出版信息

Int J Mol Sci. 2018 Nov 27;19(12):3756. doi: 10.3390/ijms19123756.

DOI:10.3390/ijms19123756
PMID:30486338
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6321351/
Abstract

In recent years, the human microbiota has gained increasing relevance both in research and clinical fields. Increasing studies seem to suggest the centrality of the microbiota and its composition both in the development and maintenance of what we call "health" and in generating and/or favoring (those cases in which the microbiota's complex relational architecture is dysregulated) the onset of pathological conditions. The complex relationships between the microbiota and human beings, which invest core notions of biomedicine such as "health" and "individual," do concern not only problems of an empirical nature but seem to require the need to adopt new concepts and new perspectives in order to be properly analysed and utilized, especially for their therapeutic implementation. In this contribution we report and discuss some of the theoretical proposals and innovations (from the ecological component to the notion of polygenomic organism) aimed at producing this change of perspective. In conclusion, we summarily analyze what impact and what new challenges these new approaches might have on personalized/person centred/precision medicine.

摘要

近年来,人类微生物组在研究和临床领域都越来越受到重视。越来越多的研究似乎表明,微生物组及其组成在我们所谓的“健康”的发展和维持中,以及在产生和/或促进(在这种情况下,微生物组的复杂关系结构失调)病理状况的发生中具有核心地位。微生物组与人类之间的复杂关系,涉及到核心的生物医学概念,如“健康”和“个体”,不仅涉及到经验性质的问题,而且似乎需要采用新概念和新视角来进行适当的分析和利用,特别是为了实现其治疗应用。在本研究中,我们报告并讨论了一些旨在产生这种视角转变的理论建议和创新(从生态组成部分到多基因组生物体的概念)。最后,我们简要分析了这些新方法可能对个性化/以人为本/精准医学产生的影响和新挑战。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/86da/6321351/7f7872b83639/ijms-19-03756-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/86da/6321351/d9e98b6644f6/ijms-19-03756-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/86da/6321351/7f7872b83639/ijms-19-03756-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/86da/6321351/d9e98b6644f6/ijms-19-03756-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/86da/6321351/7f7872b83639/ijms-19-03756-g002.jpg

相似文献

1
I've A Feeling: Microbiota Impacting the Conceptual and Experimental Perspectives of Personalized Medicine.我有一种感觉:微生物组正在影响个性化医学的概念和实验观点。
Int J Mol Sci. 2018 Nov 27;19(12):3756. doi: 10.3390/ijms19123756.
2
Proteomics and the microbiome: pitfalls and potential.蛋白质组学与微生物组:陷阱与潜能。
Expert Rev Proteomics. 2019 Jun;16(6):501-511. doi: 10.1080/14789450.2018.1523724. Epub 2018 Sep 28.
3
[Why could gut microbiota become a medication?].[为什么肠道微生物群能成为一种药物?]
Ann Pharm Fr. 2014 Sep;72(5):325-9. doi: 10.1016/j.pharma.2014.03.005. Epub 2014 Apr 24.
4
Lipids from gut microbiota: pursuing a personalized treatment.肠道微生物群衍生的脂质:追求个体化治疗。
Trends Mol Med. 2022 Aug;28(8):631-643. doi: 10.1016/j.molmed.2022.06.001. Epub 2022 Jun 20.
5
[Application of metagenomic and culturomic technologies in fecal microbiota transplantation: a review].宏基因组学和培养组学技术在粪便微生物群移植中的应用:综述
Sheng Wu Gong Cheng Xue Bao. 2022 Oct 25;38(10):3594-3605. doi: 10.13345/j.cjb.220573.
6
[Microbiota and inflammatory bowel disease: an update.].[微生物群与炎症性肠病:最新进展。]
Recenti Prog Med. 2018 Dec;109(12):570-573. doi: 10.1701/3082.30741.
7
A metagenomic study of the gut microbiome in Behcet's disease.贝赫切特病肠道微生物组的宏基因组学研究。
Microbiome. 2018 Aug 4;6(1):135. doi: 10.1186/s40168-018-0520-6.
8
An ecological framework to understand the efficacy of fecal microbiota transplantation.理解粪便微生物群移植疗效的生态框架。
Nat Commun. 2020 Jul 3;11(1):3329. doi: 10.1038/s41467-020-17180-x.
9
Multi-omics Approaches To Decipher the Impact of Diet and Host Physiology on the Mammalian Gut Microbiome.多组学方法解析饮食和宿主生理学对哺乳动物肠道微生物组的影响。
Appl Environ Microbiol. 2020 Nov 10;86(23). doi: 10.1128/AEM.01864-20.
10
The human microbiome in health and disease: hype or hope.健康与疾病中的人类微生物组:炒作还是希望?
Acta Clin Belg. 2019 Apr;74(2):53-64. doi: 10.1080/17843286.2019.1583782. Epub 2019 Feb 27.

引用本文的文献

1
Artificial Intelligence and Precision Medicine: A New Frontier for the Treatment of Brain Tumors.人工智能与精准医学:脑肿瘤治疗的新前沿
Life (Basel). 2022 Dec 22;13(1):24. doi: 10.3390/life13010024.
2
The Yin-Yang Pharmacomicrobiomics on Treatment Response in Inflammatory Arthritides: A Narrative Review.阴阳药效微生物组学在炎症性关节炎治疗反应中的作用:叙事性综述。
Genes (Basel). 2022 Dec 28;14(1):89. doi: 10.3390/genes14010089.
3
Fecal Microbiota Transplantation in NAFLD Treatment.粪便微生物移植治疗非酒精性脂肪性肝病。

本文引用的文献

1
Insights into Pathogenic Interactions Among Environment, Host, and Tumor at the Crossroads of Molecular Pathology and Epidemiology.环境、宿主与肿瘤的致病相互作用研究进展——分子病理学与流行病学的交叉点
Annu Rev Pathol. 2019 Jan 24;14:83-103. doi: 10.1146/annurev-pathmechdis-012418-012818. Epub 2018 Aug 20.
2
Human gut microbiome: hopes, threats and promises.人类肠道微生物组:希望、威胁和承诺。
Gut. 2018 Sep;67(9):1716-1725. doi: 10.1136/gutjnl-2018-316723. Epub 2018 Jun 22.
3
Why does the microbiome affect behaviour?微生物组为什么会影响行为?
Medicina (Kaunas). 2022 Oct 30;58(11):1559. doi: 10.3390/medicina58111559.
4
Inflammatory Bowel Disease and Customized Nutritional Intervention Focusing on Gut Microbiome Balance.炎症性肠病与个性化营养干预:关注肠道微生物组平衡
Nutrients. 2022 Oct 3;14(19):4117. doi: 10.3390/nu14194117.
5
Editorial of Special Issue "The Interplay of Microbiome and Immune Response in Health and Diseases-2nd Edition".特刊编辑按语:“微生物组与免疫反应在健康与疾病中的相互作用——第 2 版”
Int J Mol Sci. 2022 Jun 28;23(13):7169. doi: 10.3390/ijms23137169.
6
Coix Seed Consumption Affects the Gut Microbiota and the Peripheral Lymphocyte Subset Profiles of Healthy Male Adults.薏苡仁摄入影响健康成年男性的肠道微生物群和外周淋巴细胞亚群谱。
Nutrients. 2021 Nov 15;13(11):4079. doi: 10.3390/nu13114079.
7
Microbiota, Bacterial Carbonic Anhydrases, and Modulators of Their Activity: Links to Human Diseases?微生物群、细菌碳酸酐酶及其活性调节剂:与人类疾病有关吗?
Mediators Inflamm. 2021 Nov 11;2021:6926082. doi: 10.1155/2021/6926082. eCollection 2021.
8
Cardiovascular Diseases and Pharmacomicrobiomics: A Perspective on Possible Treatment Relevance.心血管疾病与药物微生物组学:关于潜在治疗相关性的观点
Biomedicines. 2021 Sep 28;9(10):1338. doi: 10.3390/biomedicines9101338.
9
Immunity in amyotrophic lateral sclerosis: blurred lines between excessive inflammation and inefficient immune responses.肌萎缩侧索硬化症中的免疫:过度炎症与低效免疫反应之间的界限模糊
Brain Commun. 2020 Aug 13;2(2):fcaa124. doi: 10.1093/braincomms/fcaa124. eCollection 2020.
10
Targeting gut microbiota for precision medicine: Focusing on the efficacy and toxicity of drugs.针对肠道微生物群的精准医学:聚焦药物的疗效与毒性
Theranostics. 2020 Sep 14;10(24):11278-11301. doi: 10.7150/thno.47289. eCollection 2020.
Nat Rev Microbiol. 2018 Oct;16(10):647-655. doi: 10.1038/s41579-018-0014-3.
4
An overview on the interplay between nutraceuticals and gut microbiota.营养保健品与肠道微生物群相互作用的概述。
PeerJ. 2018 Mar 13;6:e4465. doi: 10.7717/peerj.4465. eCollection 2018.
5
Integrative analysis of exogenous, endogenous, tumour and immune factors for precision medicine.外源性、内源性、肿瘤和免疫因素的综合分析,用于精准医学。
Gut. 2018 Jun;67(6):1168-1180. doi: 10.1136/gutjnl-2017-315537. Epub 2018 Feb 6.
6
Preliminary Comparison of Oral and Intestinal Human Microbiota in Patients with Colorectal Cancer: A Pilot Study.结直肠癌患者口腔和肠道人类微生物群的初步比较:一项试点研究。
Front Microbiol. 2018 Jan 12;8:2699. doi: 10.3389/fmicb.2017.02699. eCollection 2017.
7
Functional horizontal gene transfer from bacteria to eukaryotes.从细菌到真核生物的功能水平基因转移。
Nat Rev Microbiol. 2018 Feb;16(2):67-79. doi: 10.1038/nrmicro.2017.137. Epub 2017 Nov 27.
8
The Intra-Dependence of Viruses and the Holobiont.病毒与全生物的内在依存关系
Front Immunol. 2017 Nov 9;8:1501. doi: 10.3389/fimmu.2017.01501. eCollection 2017.
9
The Origin and Diversification of Mitochondria.线粒体的起源与多样化。
Curr Biol. 2017 Nov 6;27(21):R1177-R1192. doi: 10.1016/j.cub.2017.09.015.
10
Engineering Diagnostic and Therapeutic Gut Bacteria.工程诊断和治疗肠道细菌。
Microbiol Spectr. 2017 Oct;5(5). doi: 10.1128/microbiolspec.BAD-0020-2017.